Samus Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Samus Therapeutics

Access the complete profile.

Samus Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	10 South Main Street Topsfield, MA 01983

Note: Revenues for privately held companies are statistical evaluations.


Samus Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Samus Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Samus Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Samus Therapeutics Annual Revenue and Growth Rate

Samus Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Samus Therapeutics's revenues are gauged from an analysis of company filings.

Samus Therapeutics's Income Statement (based on Industry Averages)

Samus Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Samus Therapeutics is developing and marketing. Samus Therapeutics doesn't have any recent trademark applications, indicating Samus Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SAMUS Pharmaceuticals for the treatment of cancer and neurological disorders	12/06/2016
SAMUS THERAPEUTICS Pharmaceuticals for the treatment of cancer and neurological disorders	12/06/2016

See all trademarks and details in the Full Report.

Market Share of Samus Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Samus Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Samus Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ABIOMED	Danvers, MA	100
NEW ENGLAND BIOLABS	Ipswich, MA	36
WPL	Beverly, MA	7
GLOUCESTER MARINE GENOMICS INSTITUTE	Gloucester, MA	3
VELICO MEDICAL	Beverly, MA	2
MEDICINAL GENOMICS	Beverly, MA	2

Other Companies at 10 South Main Street, Topsfield MA

Company	Headquarters	Revenue ($ MM)
BARKER FINANCIAL GROUP	Topsfield, MA	100
HIGHQUEST PARTNERS	Topsfield, MA	98
DANFORTH/CAREY	Topsfield, MA	17

Future Competition: Samus Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Samus Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)